If We Do Not Prevent Liver Disease Now, the World Will Face Devastating Loss of Both Life and Financial Resources Global Liver Institute’s “Global State of Liver Health” Report Exposes Alarming...
Global Liver Institute Recognized as a Healthy People 2030 Champion (Washington, DC – October 4, 2022) — Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating...
Rates of Liver Cancers Are Going Up – and Communities of Color Face the Most Risk Global Liver Institute Launches 5th Annual #OctoberIs4Livers Campaign: Driving Equity in Liver Cancers Washington,...
After brushing off the symptoms of shoulder pain, fatigue, and GI issues as part of my career as a paramedic, I eventually scheduled an appointment with my primary care physician in 2009 when I...
St. Patrick’s Day seems to be a recurring theme throughout my liver cancer journey: I was diagnosed with hepatocellular carcinoma on March 17, 2017 and exactly one year later, I received the...
“You have liver cancer.” It’s a sentence that nobody wants to hear, but far too many people have heard (likely hundreds of thousands this year). Despite the prominent position that cancer has played...
People living with NASH, patients and families, whose lives and livelihoods are at risk from a liver disease few outside of a small circle of academic and clinical experts had heard of a few years...
GLI Recognizes and Supports Primary Biliary Cholangitis Day Global Liver Institute (GLI) is proud to support liver patients worldwide in recognition of International Primary Biliary Cholangitis...
Global Liver Institute Congratulates Dr. Monica Bertagnolli for Imminent Appointment as Director of the National Cancer Institute Washington, DC – August 12, 2022 – As leaders in the liver cancers...
Recent News
Congress returns with budget reconciliation at the top of the to-do list. Key House authorizing committees are slated to kick off markups on their respective budget reconciliation instructions that will be combined into a single reconciliation bill. Join Global Liver...
Big Wins for Rare Liver Disease: New Codes, Drug Approvals, and Global Advocacy – Pediatric and Rare Liver Diseases News New ICD-10 Codes for Fontan-Associated Conditions The introduction of new, dedicated ICD-10 diagnosis codes for Fontan-associated...
Treatment Advances & Prevention ResearchGlobal Liver Institute brings you key updates in liver cancer research and treatment. We highlight the final results from a Phase II combination therapy trial, along with encouraging data on the integration of immunotherapy...
Liver Health Insights, Events, and a Global ChallengeA Note from the Director, Dr. Sharon H. Jaycox I recently conducted a workshop titled: Advanced Strategies: Navigating Credible Research and Accessing Clinical Trial Opportunities, as part of GLI’s A4, program with...
GLI Statement on the CMS 2026 Medicare Advantage and Part D Final Rule and Anti-Obesity Medication Coverage WASHINGTON, DC – On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid (CMS) released the 2026 Medicare Advantage and Part D Final Rule and...
